Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development.

MLA

van der Stoep, Marco, et al. “Elimination of Macrophages Drives LXR-Induced Regression Both in Initial and Advanced Stages of Atherosclerotic Lesion Development.” Biochemical Pharmacology, vol. 86, no. 11, Dec. 2013, pp. 1594–602. EBSCOhost, https://doi.org/10.1016/j.bcp.2013.09.019.

APA

van der Stoep, M., Li, Z., Calpe-Berdiel, L., van der Sluis, R. J., Saleh, P., McKinnon, H. J., Smit, M. J., Korporaal, S. J. A., Van Berkel, T. J. C., Van Eck, M., & Hoekstra, M. (2013). Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development. Biochemical Pharmacology, 86(11), 1594–1602. https://doi.org/10.1016/j.bcp.2013.09.019

Chicago

van der Stoep, Marco, Zhaosha Li, Laura Calpe-Berdiel, Ronald J. van der Sluis, Peshtiwan Saleh, Heather J. McKinnon, Martin J. Smit, et al. 2013. “Elimination of Macrophages Drives LXR-Induced Regression Both in Initial and Advanced Stages of Atherosclerotic Lesion Development.” Biochemical Pharmacology 86 (11): 1594–1602. doi:10.1016/j.bcp.2013.09.019.